Prosecution Insights
Last updated: August 18, 2026

Examiner: STIGELL, THEODORE J

Tech Center 3700 • Art Units: 3763 3783 3792

This examiner grants 78% of resolved cases

Performance Statistics

78.3%
Allow Rate
+8.3% vs TC avg
1,307
Total Applications
+14.8%
Interview Lift
1180
Avg Prosecution Days
Based on 1266 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
28.9%
§102 Novelty
32.9%
§103 Obviousness
21.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17970816 SYSTEMS AND METHODS FOR PRODUCING MIXTURES Final Rejection Boston Scientific Scimed, Inc.
17567620 IMPLANTATION NEEDLE FOR INSERTING A SUBCUTANEOUSLY INSERTABLE ELEMENT INTO A BODY TISSUE Non-Final OA Roche Diabetes Care, Inc.
18173673 POINT OF CARE DRUG DELIVERY APPARATUS AND METHOD Final Rejection Genentech, Inc.
18715639 SEQUENCING AND STRATEGIES FOR ENHANCING INTRAVASCULAR THROMBUS DISRUPTION WITH PHASE-CHANGE CAVITATION ENHANCING AGENTS Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
18683021 NON-ADHESIVE MEDICAL ATTACHMENT ARTICLES USING MICRONEEDLES Non-Final OA SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
18344494 AUTO-INJECTOR AND RELATED METHODS OF USE Non-Final OA Regeneron Pharmaceuticals, Inc.
18772862 Connector Assembly Non-Final OA Becton, Dickinson and Company
18347672 MEDICAL DEVICE Non-Final OA TERUMO KABUSHIKI KAISHA
19211805 ON-BODY INTERLOCK FOR DRUG DELIVERY DEVICE Non-Final OA INSULET CORPORATION
18245191 Minimally Invasive and Semi-Automated Myocardial Injection Device Final Rejection University of South Carolina
18034523 Electronic system for a drug delivery device and drug delivery device Non-Final OA Sanofi
18687942 Activation member and subassembly for a medicament delivery device Non-Final OA SHL Medical AG
18687754 Mechanical Clamshell Cathlock Non-Final OA Bard Peripheral Vascular, Inc.
18497431 APPARATUS AND METHOD FOR CONTROLLING INJECTION OF DRUG INTO OBJECT, AND RECORDING MEDIUM STORING COMPUTER PROGRAM FOR PERFORMING THE METHOD Non-Final OA IUCF-HYU (Industry-University Cooperation Foundation Hanyang University)
17995198 Subcutaneous Port With Locking Member Non-Final OA Takeda Pharmaceutical Company Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month